Mechanisms of HBx Mediated Liver Cancer: Multiple Pathways and Opportunities

Mark A.,Alla Arzumanyan,Tiffany Friedman,N. Lale,Zhaorui Lian,Marcia M.,Joyce Kang,Helena M. G. P. V. Reis,Jingbo Pan,Jie Liu,Patrick Arbuthnot,Michael Kew

DOI: https://doi.org/10.5772/27962

2012-01-01

Abstract:IntroductionChronic hepatitis B virus (HBV) infection is associated with a high risk for the development of chronic liver diseases (CLDs) which include hepatitis, cirrhosis and hepatocellular carcinoma (HCC).HCC is among the top five most prevalent tumor types worldwide, has few effective treatment options, and is highly lethal.The pathogenesis of CLD and HCC is immune mediated, and the virus has developed a number of defense mechanisms that essentially prevent infected cells from being effectively eliminated by the immune system.This, in part, involves the sustained, high level expression of the virus encoded protein, hepatitis B x antigen (HBx).Recent work has shown that HBx blocks pathways of innate immunity (Kumar et al., 2011;Wei et al., 2010), thereby blunting the development of adaptive immunity that is central to virus elimination.In addition, HBx inhibits immune mediated apoptosis by multiple pathways, including those mediated by Fas and tumor necrosis factor alpha (TNF).In this context, HBx has been shown to up-regulate TNF expression (Lara-Pezzi et al., 1998), which is thought to kill uninfected hepatocytes more readily than infected cells, thereby promoting expansion of the virus within the liver, since virus infected hepatocytes would preferentially regenerate following a bout of chronic hepatitis.HBx also switches the growth signals mediated by elevated transforming growth factor beta 1 (TGF1) from that of negative growth regulation to that of positive growth regulation.TGF1 is a transcriptional target of HBx (Yoo et al., 1996), suggesting that HBx expression in the liver promotes fibrogenesis and the development of cirrhosis.Within the infected hepatocyte, HBx blocks the action of tumor suppressors, such as p53 and Rb (Feitelson et al., 2008), and up-regulates the expression of selected host genes that strongly promote hepatocarcinogenesis even in the absence of HBx (see below).Recent work has also